The company is using the funding to develop its automated tissue sectioning device, SectionStar, in preparation for a launch into the non-clinical lab market, according to the release. Its eventual goal is to launch the device, which aids in the processing and interpretation of human and animal tissues, into the clinical lab market.
“… AI-driven algorithms for interpretation of human tissues — particularly cancer — when examined on a cellular level are vulnerable to the variability in the quality of those tissue cross-sections,” Clarapath CEO Eric Feinstein said. “Clarapath’s SectionStar consolidates many manual cutting, quality control and decision making steps into one piece of equipment, resulting in better quality tissue sections, faster processing efficiencies, and lower overall costs, all while providing richer data sets on those tissue specimens.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
